CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.66
+1.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 11.29x
- P/E 2027E
- 81.18x
- P/E 2028E
- 12.62x
- P/S forward
- 1.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.35x
- PEG TTM
- —
- Price / book
- 0.96x
- Price / sales
- 0.95x
- Price / cash flow
- 1.74x
Enterprise value
- Enterprise value
- $329.6M
- EV / sales
- 0.71x
- EV / EBITDA
- 1.32x
- EV / EBIT
- 1.52x
- Market cap
- $441.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026